Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
2021 · Vaccine · 115 citations
https://doi.org/10.1016/j.vaccine.2021.01.055
J
Jakob P. Cramer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
6.6K
Citations
40
h-index
82
i10-index
Jakob P. Cramer is an academic researcher from Takeda (Switzerland). The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & Travel-related health issues. The author has an h-index of 40, co-authored 115 publications.
ORCID: 0009-0005-1268-5750Papers by this author
worksArtesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis
2013 · Malaria Journal · 76 citations
https://doi.org/10.1186/1475-2875-12-241
Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study
2016 · Vaccine · 24 citations
https://doi.org/10.1016/j.vaccine.2016.07.029
Clinical relevance of different biomarkers in imported plasmodium falciparum malaria in adults: a case control study
2013 · Malaria Journal · 17 citations
https://doi.org/10.1186/1475-2875-12-246
Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial
2020 · Vaccine · 10 citations
https://doi.org/10.1016/j.vaccine.2020.05.081
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat